From the MRI Laboratory, Hospital for Special Surgery, New York, NY.

Received for publication March 7, 2022; and accepted for publication, after revision, June 29, 2022.

Conflicts of interest and sources of funding: the Hospital for Special Surgery receives institutional research funding from GE Healthcare and Siemens Healthineers. Dr Sneag received a Seed Grant from International Skeletal Society for research on ferumoxytol.

Correspondence to: Darryl B. Sneag, MD, 535 East 70th St, New York, NY 10021. E-mail: [email protected].